Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients

Journal of Internal Medicine

Volumn 269, Issue 2, 2011, Pages 172-181

  Zoccali, C ^a   Postorino, M ^a   Marino, C ^a   Pizzini, P ^a   Cutrupi, S ^a   Tripepi, G ^a  

^a CNR   (Italy)

Author keywords

Adiponectin; Cardiovascular death; ESRD; Leptin; Survival; Waist circumference; Waist hip ratio

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DEATH; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSE TISSUE; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; HEMODYNAMICS; HUMANS; ITALY; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RENAL DIALYSIS; WAIST CIRCUMFERENCE;

EID: 78651065716     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02288.x     Document Type: Article

References (39)

1. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-72.
2. Cordeiro AC, Qureshi AR, Stenvinkel P et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010; 25: 562-8.
3. Carrero JJ, Cordeiro AC, Lindholm B, Stenvinkel P. The emerging pleiotrophic role of adipokines in the uremic phenotype. Curr Opin Nephrol Hypertens 2010; 19: 37-42.
4. Zoccali C, Mallamaci F. Adiponectin and renal disease progression: another epidemiologic conundrum? Kidney Int 2007; 71: 1195-7.
5. Scholze A, Rattensperger D, Zidek W, Tepel M. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring) 2007; 15: 1617-22.
6. Mallamaci F, Tripepi G, Zoccali C. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. J Nephrol 2005; 18: 464-8.
7. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-41.
8. Takemoto F, Katori H, Sawa N et al. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients - a Japanese prospective eight-year study. Nephron Clin Pract 2009; 111: c12-20.
9. Rao M, Li L, Tighiouart H et al. Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant 2008; 23: 2619-28.
10. Drechsler C, Krane V, Winkler K et al. Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients. Kidney Int 2009; 76: 567-75.
11. Majane OH, Woodiwiss AJ, Maseko MJ et al. Impact of age on the independent association of adiposity with pulse-wave velocity in a population sample of African ancestry. Am J Hypertens 2008; 21: 936-42.
12. Karter AJ, Mayer-Davis EJ, Selby JV et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes 1996; 45: 1547-55.
13. Srikanthan P, Seeman TE, Karlamangla AS. Waist-hip-ratio as a predictor of all-cause mortality in high-functioning older adults. Ann Epidemiol 2009; 19: 724-31.
14. Silventoinen K, Jousilahti P, Vartiainen E, Tuomilehto J. Appropriateness of anthropometric obesity indicators in assessment of coronary heart disease risk among Finnish men and women. Scand J Public Health 2003; 31: 283-90.
15. Cox BD, Whichelow MJ, Prevost AT. The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord 1998; 22: 966-73.
16. Norton GR, Majane OH, Libhaber E et al. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity. J Hypertens 2009; 27: 1873-83.
17. Grobbee DE, Hoes AW, eds. Modification and interaction. Clinical Epidemiology. Principles, Methods and Applications for Clinical Research. London: Jones & Bartlett, 2009; 38-48.
18. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1-452.
19. Jager KJ, Zoccali C, Macleod A et al. Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-60.
20. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537-45.
21. Stenvinkel P. Leptin - a new hormone of definite interest for the nephrologist. Nephrol Dial Transplant 1998; 13: 1099-101.
22. Zoccali C, Mallamaci F, Tripepi G. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int Suppl 2003; 84: S65-8.
23. Xu Q, Wang YH, Tong WJ et al. Interaction and relationship between angiotensin converting enzyme gene and environmental factors predisposing to essential hypertension in Mongolian population of China. Biomed Environ Sci 2004; 17: 177-86.
24. Demerath E, Towne B, Blangero J et al. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann Hum Biol 2001; 28: 664-78.
25. Tank J, Heusser K, Diedrich A et al. Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J Clin Endocrinol Metab 2008; 93: 4974-8.
26. Wen W, Cai Q, Xiang YB et al. The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk. Cancer 2008; 112: 2409-16.
27. Slattery ML, Curtin K, Sweeney C et al. Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk. Obesity (Silver Spring) 2008; 16: 339-47.
28. Boden G, Chen X, Mozzoli M et al. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996; 81: 3419-23.
29. Kelesidis T, Kelesides I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010; 152: 93-100.
30. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc Med 2007; 17: 206-11.
31. Grassi G, Diez J. Obesity-related cardiac and vascular structural alterations: beyond blood pressure overload. J Hypertens 2009; 27: 1750-2.
32. Zoccali C, Benedetto FA, Mallamaci F et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2004; 15: 1029-37.
33. Paolisso G, Tagliamonte MR, Galderisi M et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 1999; 34: 1047-52.
34. Zoccali C, Mallamaci F, Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 2003; 21: 29-36.
35. Mitsuhashi H, Yatsuya H, Tamakoshi K et al. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension 2007; 49: 1448-54.
36. Shibata R, Ouchi N, Ito M et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004; 10: 1384-9.
37. Pannacciulli N, Vettor R, Milan G et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003; 88: 1748-52.
38. Karason K, Wallentin I, Larsson B, Sjostrom L. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 1997; 315: 912-6.
39. Kleinbaum DG, Klein M. Survival Analysis. A Self Learning Text, 2nd edn. New York, USA: Springer, 2005; 103.